Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database
- PMID: 19224301
- PMCID: PMC2758965
- DOI: 10.1007/s11999-009-0749-2
Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database
Abstract
Current stratification of prognosis in patients with epithelioid sarcoma (ES) is based largely on data reported by individual centers with a limited number of patients. We sought to identify the important prognostic parameters using the Surveillance, Epidemiology, and End Results (SEER) database. We identified 441 patients with ES in the database and extracted information regarding patient demographics and clinical characteristics. Kaplan-Meier, log-rank, and Cox regression were used for analysis. Disease-specific survival declined until 100 months after diagnosis after which survival was unrelated to epithelioid sarcoma. The overall incidence of ES during 2005 was 0.041 per 100,000. The reported incidence has increased since 1973, with an annual percentage change of 5.217%. On multivariate analysis, only age younger than 16 years, local stage of disease, or negative nodes and surgical resection of the tumor predicted better disease-specific survival. We observed no increase in survival by comparing decades of diagnosis since 1986. The SEER database shows only age younger than 16 years, negative nodes, or local stage of disease and operability of primary disease independently predict survival in patients with ES.
Level of evidence: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.
Figures
References
-
- American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2003.
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12187164', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12187164/'}]}
- Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002;40(8 suppl):IV-19–25. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1245/s10434-007-9628-9', 'is_inner': False, 'url': 'https://doi.org/10.1245/s10434-007-9628-9'}, {'type': 'PubMed', 'value': '17909905', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17909905/'}]}
- Baratti D, Pennacchioli E, Casali PG, Bertulli R, Lozza L, Olmi P, Collini P, Radaelli S, Fiore M, Gronchi A. Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol. 2007;14:3542–3551. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '5654506', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/5654506/'}]}
- Bliss BO, Reed RJ. Large cell sarcomas of tendon sheath. Am J Clin Pathol. 1968;49:776–781. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '3392084', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/3392084/'}]}
- Bos GD, Pritchard DJ, Reiman HM, Dobyns JH, Ilstrup DM, Landon GC. Epithelioid sarcoma: an analysis of fifty-one cases. J Bone Joint Surg Am. 1988;70:862–870. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
